{"id":"https://openalex.org/W4392701409","doi":"https://doi.org/10.3389/fimmu.2024.1273280","title":"Engineered therapeutic antibodies with mannose 6-phosphate analogues as a tool to degrade extracellular proteins","display_name":"Engineered therapeutic antibodies with mannose 6-phosphate analogues as a tool to degrade extracellular proteins","publication_year":2024,"publication_date":"2024-03-12","ids":{"openalex":"https://openalex.org/W4392701409","doi":"https://doi.org/10.3389/fimmu.2024.1273280","pmid":"https://pubmed.ncbi.nlm.nih.gov/38533506","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10964947"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2024.1273280","doi":"https://doi.org/10.3389/fimmu.2024.1273280","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2024.1273280","pdf_url":null,"source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3389/fimmu.2024.1273280","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060417203","display_name":"Morgane Daurat","orcid":"https://orcid.org/0000-0001-6448-3775","observed_orcids":["https://orcid.org/0000-0001-6448-3775","https://orcid.org/0000-0003-4427-8306"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Morgane Daurat","raw_affiliation_strings":["NanoMedSyn, Montpellier, France","NMS - NanoMedSyn (15 Avenue Charles Flahault, 34093 Montpellier cedex 05, France - France)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NanoMedSyn, Montpellier, France","institution_ids":[]},{"raw_affiliation_string":"NMS - NanoMedSyn (15 Avenue Charles Flahault, 34093 Montpellier cedex 05, France - France)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087146739","display_name":"Corentin Gauthier","orcid":"https://orcid.org/0000-0002-8174-5551","observed_orcids":["https://orcid.org/0000-0002-8174-5551"]},"institutions":[{"id":"https://openalex.org/I11935315","display_name":"\u00c9cole Nationale Sup\u00e9rieure de Chimie de Montpellier","ror":"https://ror.org/03sgyqj04","country_code":"FR","type":"education","lineage":["https://openalex.org/I11935315","https://openalex.org/I19894307"]},{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I19894307","display_name":"Universit\u00e9 de Montpellier","ror":"https://ror.org/051escj72","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307"]},{"id":"https://openalex.org/I4210145258","display_name":"Institut des Biomol\u00e9cules Max Mousseron","ror":"https://ror.org/05d1e6v30","country_code":"FR","type":"facility","lineage":["https://openalex.org/I11935315","https://openalex.org/I1294671590","https://openalex.org/I19894307","https://openalex.org/I4210128300","https://openalex.org/I4210145258"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Corentin Gauthier","raw_affiliation_strings":["Institut des Biomol\u00e9cules Max Mousseron (IBMM), University of Montpellier, CNRS, ENSCM, Montpellier, France","NanoMedSyn, Montpellier, France","IBMM - Institut des Biomol\u00e9cules Max Mousseron [P\u00f4le Chimie Balard] (CNRS - 1919 Route de Mende\r\n34293 Montpellier cedex 5 - France)","NMS - NanoMedSyn (15 Avenue Charles Flahault, 34093 Montpellier cedex 05, France - France)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut des Biomol\u00e9cules Max Mousseron (IBMM), University of Montpellier, CNRS, ENSCM, Montpellier, France","institution_ids":["https://openalex.org/I11935315","https://openalex.org/I1294671590","https://openalex.org/I19894307","https://openalex.org/I4210145258"]},{"raw_affiliation_string":"NanoMedSyn, Montpellier, France","institution_ids":[]},{"raw_affiliation_string":"IBMM - Institut des Biomol\u00e9cules Max Mousseron [P\u00f4le Chimie Balard] (CNRS - 1919 Route de Mende\r\n34293 Montpellier cedex 5 - France)","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I4210145258"]},{"raw_affiliation_string":"NMS - NanoMedSyn (15 Avenue Charles Flahault, 34093 Montpellier cedex 05, France - France)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018140154","display_name":"Khaled El Cheikh","orcid":"https://orcid.org/0000-0001-6109-5312","observed_orcids":["https://orcid.org/0000-0001-6109-5312"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Khaled El Cheikh","raw_affiliation_strings":["NanoMedSyn, Montpellier, France","NMS - NanoMedSyn (15 Avenue Charles Flahault, 34093 Montpellier cedex 05, France - France)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NanoMedSyn, Montpellier, France","institution_ids":[]},{"raw_affiliation_string":"NMS - NanoMedSyn (15 Avenue Charles Flahault, 34093 Montpellier cedex 05, France - France)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059105769","display_name":"Lamiaa M. A. Ali","orcid":"https://orcid.org/0000-0003-1176-5335","observed_orcids":["https://orcid.org/0000-0003-1176-5335"]},"institutions":[{"id":"https://openalex.org/I11935315","display_name":"\u00c9cole Nationale Sup\u00e9rieure de Chimie de Montpellier","ror":"https://ror.org/03sgyqj04","country_code":"FR","type":"education","lineage":["https://openalex.org/I11935315","https://openalex.org/I19894307"]},{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I19894307","display_name":"Universit\u00e9 de Montpellier","ror":"https://ror.org/051escj72","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307"]},{"id":"https://openalex.org/I4210145258","display_name":"Institut des Biomol\u00e9cules Max Mousseron","ror":"https://ror.org/05d1e6v30","country_code":"FR","type":"facility","lineage":["https://openalex.org/I11935315","https://openalex.org/I1294671590","https://openalex.org/I19894307","https://openalex.org/I4210128300","https://openalex.org/I4210145258"]},{"id":"https://openalex.org/I84524832","display_name":"Alexandria University","ror":"https://ror.org/00mzz1w90","country_code":"EG","type":"education","lineage":["https://openalex.org/I84524832"]}],"countries":["EG","FR"],"is_corresponding":false,"raw_author_name":"Lamiaa M. A. Ali","raw_affiliation_strings":["Department of Biochemistry Medical Research Institute, University of Alexandria, Alexandria, Egypt","Institut des Biomol\u00e9cules Max Mousseron (IBMM), University of Montpellier, CNRS, ENSCM, Montpellier, France","Alexandria University [Alexandrie] (Al Azaritah WA Ash Shatebi, Qism Bab Sharqi, Alexandria Governorate, \u00c9gypte - Egypt)","IBMM - Institut des Biomol\u00e9cules Max Mousseron [P\u00f4le Chimie Balard] (CNRS - 1919 Route de Mende\r\n34293 Montpellier cedex 5 - France)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry Medical Research Institute, University of Alexandria, Alexandria, Egypt","institution_ids":["https://openalex.org/I84524832"]},{"raw_affiliation_string":"Institut des Biomol\u00e9cules Max Mousseron (IBMM), University of Montpellier, CNRS, ENSCM, Montpellier, France","institution_ids":["https://openalex.org/I11935315","https://openalex.org/I1294671590","https://openalex.org/I19894307","https://openalex.org/I4210145258"]},{"raw_affiliation_string":"Alexandria University [Alexandrie] (Al Azaritah WA Ash Shatebi, Qism Bab Sharqi, Alexandria Governorate, \u00c9gypte - Egypt)","institution_ids":["https://openalex.org/I84524832"]},{"raw_affiliation_string":"IBMM - Institut des Biomol\u00e9cules Max Mousseron [P\u00f4le Chimie Balard] (CNRS - 1919 Route de Mende\r\n34293 Montpellier cedex 5 - France)","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I4210145258"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091927754","display_name":"Elodie Mor\u00e8re","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I11935315","display_name":"\u00c9cole Nationale Sup\u00e9rieure de Chimie de Montpellier","ror":"https://ror.org/03sgyqj04","country_code":"FR","type":"education","lineage":["https://openalex.org/I11935315","https://openalex.org/I19894307"]},{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I19894307","display_name":"Universit\u00e9 de Montpellier","ror":"https://ror.org/051escj72","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307"]},{"id":"https://openalex.org/I4210145258","display_name":"Institut des Biomol\u00e9cules Max Mousseron","ror":"https://ror.org/05d1e6v30","country_code":"FR","type":"facility","lineage":["https://openalex.org/I11935315","https://openalex.org/I1294671590","https://openalex.org/I19894307","https://openalex.org/I4210128300","https://openalex.org/I4210145258"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Elodie Mor\u00e8re","raw_affiliation_strings":["Institut des Biomol\u00e9cules Max Mousseron (IBMM), University of Montpellier, CNRS, ENSCM, Montpellier, France","NanoMedSyn, Montpellier, France","IBMM - Institut des Biomol\u00e9cules Max Mousseron [P\u00f4le Chimie Balard] (CNRS - 1919 Route de Mende\r\n34293 Montpellier cedex 5 - France)","NMS - NanoMedSyn (15 Avenue Charles Flahault, 34093 Montpellier cedex 05, France - France)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut des Biomol\u00e9cules Max Mousseron (IBMM), University of Montpellier, CNRS, ENSCM, Montpellier, France","institution_ids":["https://openalex.org/I11935315","https://openalex.org/I1294671590","https://openalex.org/I19894307","https://openalex.org/I4210145258"]},{"raw_affiliation_string":"NanoMedSyn, Montpellier, France","institution_ids":[]},{"raw_affiliation_string":"IBMM - Institut des Biomol\u00e9cules Max Mousseron [P\u00f4le Chimie Balard] (CNRS - 1919 Route de Mende\r\n34293 Montpellier cedex 5 - France)","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I4210145258"]},{"raw_affiliation_string":"NMS - NanoMedSyn (15 Avenue Charles Flahault, 34093 Montpellier cedex 05, France - France)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047768373","display_name":"Nadir Bettache","orcid":"https://orcid.org/0000-0001-5426-7024","observed_orcids":["https://orcid.org/0000-0001-5426-7024"]},"institutions":[{"id":"https://openalex.org/I11935315","display_name":"\u00c9cole Nationale Sup\u00e9rieure de Chimie de Montpellier","ror":"https://ror.org/03sgyqj04","country_code":"FR","type":"education","lineage":["https://openalex.org/I11935315","https://openalex.org/I19894307"]},{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I19894307","display_name":"Universit\u00e9 de Montpellier","ror":"https://ror.org/051escj72","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307"]},{"id":"https://openalex.org/I4210145258","display_name":"Institut des Biomol\u00e9cules Max Mousseron","ror":"https://ror.org/05d1e6v30","country_code":"FR","type":"facility","lineage":["https://openalex.org/I11935315","https://openalex.org/I1294671590","https://openalex.org/I19894307","https://openalex.org/I4210128300","https://openalex.org/I4210145258"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nadir Bettache","raw_affiliation_strings":["Institut des Biomol\u00e9cules Max Mousseron (IBMM), University of Montpellier, CNRS, ENSCM, Montpellier, France","IBMM - Institut des Biomol\u00e9cules Max Mousseron [P\u00f4le Chimie Balard] (CNRS - 1919 Route de Mende\r\n34293 Montpellier cedex 5 - France)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut des Biomol\u00e9cules Max Mousseron (IBMM), University of Montpellier, CNRS, ENSCM, Montpellier, France","institution_ids":["https://openalex.org/I11935315","https://openalex.org/I1294671590","https://openalex.org/I19894307","https://openalex.org/I4210145258"]},{"raw_affiliation_string":"IBMM - Institut des Biomol\u00e9cules Max Mousseron [P\u00f4le Chimie Balard] (CNRS - 1919 Route de Mende\r\n34293 Montpellier cedex 5 - France)","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I4210145258"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065946860","display_name":"Magali Gary\u2010Bobo","orcid":"https://orcid.org/0000-0001-9641-212X","observed_orcids":["https://orcid.org/0000-0001-9641-212X"]},"institutions":[{"id":"https://openalex.org/I11935315","display_name":"\u00c9cole Nationale Sup\u00e9rieure de Chimie de Montpellier","ror":"https://ror.org/03sgyqj04","country_code":"FR","type":"education","lineage":["https://openalex.org/I11935315","https://openalex.org/I19894307"]},{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I19894307","display_name":"Universit\u00e9 de Montpellier","ror":"https://ror.org/051escj72","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307"]},{"id":"https://openalex.org/I4210145258","display_name":"Institut des Biomol\u00e9cules Max Mousseron","ror":"https://ror.org/05d1e6v30","country_code":"FR","type":"facility","lineage":["https://openalex.org/I11935315","https://openalex.org/I1294671590","https://openalex.org/I19894307","https://openalex.org/I4210128300","https://openalex.org/I4210145258"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Magali Gary-Bobo","raw_affiliation_strings":["Institut des Biomol\u00e9cules Max Mousseron (IBMM), University of Montpellier, CNRS, ENSCM, Montpellier, France","IBMM - Institut des Biomol\u00e9cules Max Mousseron [P\u00f4le Chimie Balard] (CNRS - 1919 Route de Mende\r\n34293 Montpellier cedex 5 - France)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut des Biomol\u00e9cules Max Mousseron (IBMM), University of Montpellier, CNRS, ENSCM, Montpellier, France","institution_ids":["https://openalex.org/I11935315","https://openalex.org/I1294671590","https://openalex.org/I19894307","https://openalex.org/I4210145258"]},{"raw_affiliation_string":"IBMM - Institut des Biomol\u00e9cules Max Mousseron [P\u00f4le Chimie Balard] (CNRS - 1919 Route de Mende\r\n34293 Montpellier cedex 5 - France)","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I4210145258"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034746349","display_name":"Alain Mor\u00e8re","orcid":"https://orcid.org/0000-0002-3269-5172","observed_orcids":["https://orcid.org/0000-0002-3269-5172"]},"institutions":[{"id":"https://openalex.org/I11935315","display_name":"\u00c9cole Nationale Sup\u00e9rieure de Chimie de Montpellier","ror":"https://ror.org/03sgyqj04","country_code":"FR","type":"education","lineage":["https://openalex.org/I11935315","https://openalex.org/I19894307"]},{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I19894307","display_name":"Universit\u00e9 de Montpellier","ror":"https://ror.org/051escj72","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307"]},{"id":"https://openalex.org/I4210145258","display_name":"Institut des Biomol\u00e9cules Max Mousseron","ror":"https://ror.org/05d1e6v30","country_code":"FR","type":"facility","lineage":["https://openalex.org/I11935315","https://openalex.org/I1294671590","https://openalex.org/I19894307","https://openalex.org/I4210128300","https://openalex.org/I4210145258"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Alain Mor\u00e8re","raw_affiliation_strings":["Institut des Biomol\u00e9cules Max Mousseron (IBMM), University of Montpellier, CNRS, ENSCM, Montpellier, France","IBMM - Institut des Biomol\u00e9cules Max Mousseron [P\u00f4le Chimie Balard] (CNRS - 1919 Route de Mende\r\n34293 Montpellier cedex 5 - France)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut des Biomol\u00e9cules Max Mousseron (IBMM), University of Montpellier, CNRS, ENSCM, Montpellier, France","institution_ids":["https://openalex.org/I11935315","https://openalex.org/I1294671590","https://openalex.org/I19894307","https://openalex.org/I4210145258"]},{"raw_affiliation_string":"IBMM - Institut des Biomol\u00e9cules Max Mousseron [P\u00f4le Chimie Balard] (CNRS - 1919 Route de Mende\r\n34293 Montpellier cedex 5 - France)","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I4210145258"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109007913","display_name":"Marcel Garcia","orcid":"https://orcid.org/0000-0002-6997-9654","observed_orcids":["https://orcid.org/0000-0002-6997-9654"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marcel Garcia","raw_affiliation_strings":["NanoMedSyn, Montpellier, France","NMS - NanoMedSyn (15 Avenue Charles Flahault, 34093 Montpellier cedex 05, France - France)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NanoMedSyn, Montpellier, France","institution_ids":[]},{"raw_affiliation_string":"NMS - NanoMedSyn (15 Avenue Charles Flahault, 34093 Montpellier cedex 05, France - France)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042608813","display_name":"Marie Maynadier","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marie Maynadier","raw_affiliation_strings":["NanoMedSyn, Montpellier, France","NMS - NanoMedSyn (15 Avenue Charles Flahault, 34093 Montpellier cedex 05, France - France)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NanoMedSyn, Montpellier, France","institution_ids":[]},{"raw_affiliation_string":"NMS - NanoMedSyn (15 Avenue Charles Flahault, 34093 Montpellier cedex 05, France - France)","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071281155","display_name":"Ilaria Basile","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Ilaria Basile","raw_affiliation_strings":["NanoMedSyn, Montpellier, France","NMS - NanoMedSyn (15 Avenue Charles Flahault, 34093 Montpellier cedex 05, France - France)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NanoMedSyn, Montpellier, France","institution_ids":[]},{"raw_affiliation_string":"NMS - NanoMedSyn (15 Avenue Charles Flahault, 34093 Montpellier cedex 05, France - France)","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5071281155"],"corresponding_institution_ids":[],"apc_list":{"value":3295,"currency":"USD","value_usd":3295},"apc_paid":{"value":3295,"currency":"USD","value_usd":3295},"fwci":1.0215,"has_fulltext":true,"cited_by_count":7,"citation_normalized_percentile":{"value":0.71240499,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":97},"biblio":{"volume":"15","issue":null,"first_page":"1273280","last_page":"1273280"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.86080002784729,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.86080002784729,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.02879999950528145,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.02019999921321869,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mannose-6-phosphate-receptor","display_name":"mannose 6-phosphate receptor","score":0.859000027179718},{"id":"https://openalex.org/keywords/lysosomal-targeting","display_name":"lysosomal targeting","score":0.7950000166893005},{"id":"https://openalex.org/keywords/therapeutic-monoclonal-antibodies","display_name":"therapeutic monoclonal antibodies","score":0.8960000276565552},{"id":"https://openalex.org/keywords/antibody-engineering","display_name":"antibody engineering","score":0.7789999842643738},{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":0.7239999771118164},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.753000020980835},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.9879999756813049},{"id":"https://openalex.org/keywords/antigen-degradation","display_name":"antigen degradation","score":0.7020000219345093},{"id":"https://openalex.org/keywords/antibody-internalization","display_name":"antibody internalization","score":0.7089999914169312},{"id":"https://openalex.org/keywords/angiogenesis-inhibition","display_name":"angiogenesis inhibition","score":0.8700000047683716},{"id":"https://openalex.org/keywords/zebrafish-embryo-model","display_name":"zebrafish embryo model","score":0.671999990940094},{"id":"https://openalex.org/keywords/autoimmune-and-inflammatory-diseases","display_name":"autoimmune and inflammatory diseases","score":0.718999981880188}],"concepts":[{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.6542331576347351},{"id":"https://openalex.org/C2775887612","wikidata":"https://www.wikidata.org/wiki/Q10809118","display_name":"Mannose","level":2,"score":0.6411832571029663},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.6391227841377258},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.57305508852005},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.550658106803894},{"id":"https://openalex.org/C139770010","wikidata":"https://www.wikidata.org/wiki/Q1339807","display_name":"Internalization","level":3,"score":0.49351823329925537},{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.41922345757484436},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3688540458679199},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.24947243928909302},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.24518966674804688},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2410421371459961}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002642","descriptor_name":"Chick Embryo","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008358","descriptor_name":"Mannose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010710","descriptor_name":"Phosphates","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015027","descriptor_name":"Zebrafish","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.3389/fimmu.2024.1273280","doi":"https://doi.org/10.3389/fimmu.2024.1273280","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2024.1273280","pdf_url":null,"source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10964947","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10964947","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10964947/pdf/fimmu-15-1273280.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmid:38533506","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38533506","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-04673649v1","doi":null,"is_oa":true,"landing_page_url":"https://hal.science/hal-04673649","pdf_url":"https://hal.science/hal-04673649v1/file/fimmu-15-1273280.pdf","source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, 2024, 15, pp.273280. ⟨10.3389/fimmu.2024.1273280⟩","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:e49cd1cf5124458e964f2415b5fa61ec","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/e49cd1cf5124458e964f2415b5fa61ec","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 15 (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2024.1273280","doi":"https://doi.org/10.3389/fimmu.2024.1273280","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2024.1273280","pdf_url":null,"source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[{"id":"https://openalex.org/G381665449","display_name":null,"funder_award_id":"ANR\u201010_INBS\u201004","funder_id":"https://openalex.org/F4320320883","funder_display_name":"Agence Nationale de la Recherche"},{"id":"https://openalex.org/G7240651115","display_name":null,"funder_award_id":"ANR-10","funder_id":"https://openalex.org/F4320320883","funder_display_name":"Agence Nationale de la Recherche"}],"funders":[{"id":"https://openalex.org/F4320320883","display_name":"Agence Nationale de la Recherche","ror":"https://ror.org/00rbzpz17"},{"id":"https://openalex.org/F4320321663","display_name":"Association Nationale de la Recherche et de la Technologie","ror":"https://ror.org/00ht2ab73"},{"id":"https://openalex.org/F4320328356","display_name":"R\u00e9gion Occitanie Pyr\u00e9n\u00e9es-M\u00e9diterran\u00e9e","ror":"https://ror.org/05mzwwx48"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4392701409.pdf","grobid_xml":"https://content.openalex.org/works/W4392701409.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W1990039456","https://openalex.org/W2016168268","https://openalex.org/W2050773934","https://openalex.org/W2079619166","https://openalex.org/W2091760375","https://openalex.org/W2093117233","https://openalex.org/W2095421286","https://openalex.org/W2115836085","https://openalex.org/W2125349610","https://openalex.org/W2133695108","https://openalex.org/W2151683271","https://openalex.org/W2157892560","https://openalex.org/W2469654157","https://openalex.org/W2538968033","https://openalex.org/W2608393717","https://openalex.org/W2766582923","https://openalex.org/W2792290561","https://openalex.org/W2887116193","https://openalex.org/W2914262128","https://openalex.org/W2956355544","https://openalex.org/W2966028626","https://openalex.org/W2999958881","https://openalex.org/W3027088126","https://openalex.org/W3045619116","https://openalex.org/W3081923621","https://openalex.org/W3120553915","https://openalex.org/W4205379795","https://openalex.org/W4205628911","https://openalex.org/W4376223983"],"related_works":["https://openalex.org/W4396842775","https://openalex.org/W4376223983","https://openalex.org/W4403660000","https://openalex.org/W4402244140","https://openalex.org/W7166264543","https://openalex.org/W4404171988","https://openalex.org/W4323031792","https://openalex.org/W4220734429","https://openalex.org/W4411811663","https://openalex.org/W7165754175"],"abstract_inverted_index":{"Inducing":[0],"the":[1,9,14,24,49,61,79,83,89,102,114,117,122,151,160,166,170,174,189,193,196,228,236,287,297,306],"degradation":[2,288],"of":[3,16,26,51,82,98,104,121,169,200,240,262,289,313],"pathological":[4],"soluble":[5,135,290],"antigens":[6,213,291],"could":[7],"be":[8],"key":[10],"to":[11,43,57,60,86,111,159,202,217,245,308],"greatly":[12],"enhancing":[13],"efficacy":[15,239],"therapeutic":[17,123,298],"monoclonal":[18],"antibodies":[19,132,161,171,314],"(mAbs),":[20],"extensively":[21],"used":[22],"in":[23,39,101,227,249,257,265,277,296],"treatment":[25,50],"autoimmune":[27,316],"and":[28,116,146,181,183,224,242,252,264,292,317],"inflammatory":[29,318],"disorders":[30],"or":[31,172],"cancer.":[32],"Lysosomal":[33],"targeting":[34],"has":[35,305],"gained":[36],"increasing":[37],"interest":[38],"recent":[40],"years":[41],"due":[42],"its":[44],"pharmaceutical":[45],"applications":[46],"far":[47],"beyond":[48],"lysosomal":[52],"diseases,":[53],"as":[54],"a":[55,105,185,258,293,310],"way":[56],"address":[58],"proteins":[59,84],"lysosome":[62],"for":[63,188,195,315],"eventual":[64],"degradation.":[65],"Mannose":[66],"6-phosphonate":[67],"derivatives":[68],"(M6Pn),":[69],"called":[70],"AMFA,":[71],"are":[72],"unique":[73],"glycovectors":[74],"that":[75,108,270,283],"can":[76],"significantly":[77,237],"enhance":[78],"cellular":[80,206],"internalization":[81],"conjugated":[85],"AMFA":[87,96,126,157,201,284],"via":[88],"cation-independent":[90],"mannose":[91,302],"6-phosphate":[92,303],"receptor":[93],"(M6PR)":[94],"pathway.":[95],"engineering":[97,127],"mAbs":[99],"results":[100,281],"generation":[103],"bifunctional":[106],"antibody":[107],"is":[109],"designed":[110],"bind":[112],"both":[113],"antigen":[115],"M6PR.":[118],"The":[119,198,212],"improvement":[120],"potential":[124,307],"by":[125,222],"was":[128,272],"investigated":[129],"using":[130],"two":[131],"directed":[133,139,149],"against":[134,140,150],"antigens:":[136],"infliximab":[137],"(IFX),":[138],"tumor":[141],"necrosis":[142],"factor":[143,155],"\u03b1":[144],"(TNF-\u03b1),":[145],"bevacizumab":[147],"(BVZ),":[148],"vascular":[152],"endothelial":[153],"growth":[154],"(VEGF).":[156],"conjugations":[158,178],"were":[162,179,214],"performed":[163],"either":[164],"on":[165,173],"oligosaccharidic":[167],"chains":[168],"lysine":[175],"residues.":[176],"Both":[177],"controlled":[180],"reproducible":[182],"provided":[184],"novel":[186],"affinity":[187,194],"M6PR":[190],"without":[191],"altering":[192],"antigen.":[197],"grafting":[199,285],"mAb":[203],"increased":[204],"their":[205,246],"uptake":[207],"through":[208],"an":[209],"M6PR-dependent":[210],"mechanism.":[211],"also":[215,234],"2.6":[216],"5.7":[218],"times":[219],"more":[220,273],"internalized":[221],"mAb-AMFA":[223],"rapidly":[225],"degraded":[226],"cells.":[229],"Additional":[230],"cell":[231],"culture":[232],"studies":[233,256],"proved":[235],"higher":[238],"IFX-AMFA":[241],"BVZ-AMFA":[243,271],"compared":[244],"unconjugated":[247],"counterparts":[248],"inhibiting":[250],"TNF-\u03b1":[251],"VEGF":[253],"activities.":[254],"Finally,":[255],"zebrafish":[259],"embryo":[260],"model":[261],"angiogenesis":[263],"xenografted":[266],"chick":[267],"embryos":[268],"showed":[269],"effective":[274],"than":[275],"BVZ":[276],"reducing":[278],"angiogenesis.":[279],"These":[280],"demonstrate":[282],"induces":[286],"significant":[294],"increase":[295],"efficacy.":[299],"Engineering":[300],"with":[301],"analogues":[304],"develop":[309],"new":[311],"class":[312],"diseases.":[319]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2024-03-13T00:00:00"}